Crossmark

Sub-acute oral exposure to lowest observed adverse effect level of nivalenol exacerbates atopic dermatitis in mice via direct activation of mitogen-activated protein kinase signal in antigen-presenting cells

Crossref DOI link: https://doi.org/10.1007/s00204-024-03740-3

Published Online: 2024-04-14

Published Print: 2024-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Matsuzaka, Reo

Yamaguchi, Hiroki

Ohira, Chiharu

Kurita, Tomoe

Iwashita, Naoki

Takagi, Yoshiichi

Nishino, Tomomi

Noda, Kyoko

Sugita, Kazutoshi

Kushiro, Masayo

Miyake, Shiro

Fukuyama, Tomoki https://orcid.org/0000-0003-3510-3272
Funding

Funding for this research was provided by:

Tojuro Iijima Foundation for Food Science and Technology
License Information

Text and Data Mining valid from 2024-04-14

Version of Record valid from 2024-04-14
More Information

Article History

Received: 4 March 2024

Accepted: 18 March 2024

First Online: 14 April 2024

Declarations

:

: The authors declare no actual or potential competing financial interests.

: Not applicable.

: All aspects of the in vivo study were conducted in accordance with the Animal Care and Use Program of Azabu University (Approval No. 220316-46).

Document is current

Any future updates will be listed below